- Home
- PMCB vs DOMH Comparison
PMCB vs DOMH Comparison
Compare PMCB & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- DOMH
- Stock Information
- Founded
- PMCB 1996
- DOMH 1967
- Country
- PMCB United States
- DOMH United States
- Employees
- PMCB N/A
- DOMH N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- PMCB Health Care
- DOMH Health Care
- Exchange
- PMCB Nasdaq
- DOMH Nasdaq
- Market Cap
- PMCB 13.9M
- DOMH 12.1M
- IPO Year
- PMCB N/A
- DOMH N/A
- Fundamental
- Price
- PMCB $1.64
- DOMH $1.70
- Analyst Decision
- PMCB
- DOMH
- Analyst Count
- PMCB 0
- DOMH 0
- Target Price
- PMCB N/A
- DOMH N/A
- AVG Volume (30 Days)
- PMCB 57.4K
- DOMH 9.8K
- Earning Date
- PMCB 12-13-2024
- DOMH 11-08-2024
- Dividend Yield
- PMCB N/A
- DOMH N/A
- EPS Growth
- PMCB N/A
- DOMH N/A
- EPS
- PMCB 0.54
- DOMH N/A
- Revenue
- PMCB N/A
- DOMH $12,589,000.00
- Revenue This Year
- PMCB N/A
- DOMH N/A
- Revenue Next Year
- PMCB N/A
- DOMH N/A
- P/E Ratio
- PMCB $3.06
- DOMH N/A
- Revenue Growth
- PMCB N/A
- DOMH 1117.50
- 52 Week Low
- PMCB $1.39
- DOMH $1.50
- 52 Week High
- PMCB $2.58
- DOMH $3.20
- Technical
- Relative Strength Index (RSI)
- PMCB 40.27
- DOMH 47.43
- Support Level
- PMCB $1.72
- DOMH $1.52
- Resistance Level
- PMCB $1.94
- DOMH $1.77
- Average True Range (ATR)
- PMCB 0.17
- DOMH 0.10
- MACD
- PMCB -0.01
- DOMH -0.00
- Stochastic Oscillator
- PMCB 9.27
- DOMH 64.29
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.